A welcome study from Belgium showing that Penthrox provides substantial time and cost savings per patient in emergency care. The study is based on several assumptions, one of which is government reimbursement. This is why it is so important we get government reimbursement in Germany.
https://www.researchgate.net/profile/Said-Hachimi-Idrissi/publication/350468965_Healthcare_resource_use_and_cost_implications_of_low_dose_methoxyflurane_for_severe_trauma-related_pain_a_qualitative_study/links/6062f83392851cd8ce76693a/Healthcare-resource-use-and-cost-implications-of-low-dose-methoxyflurane-for-severe-trauma-related-pain-a-qualitative-study.pdf
A welcome study from Belgium showing that Penthrox provides...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.005(1.15%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 45.0¢ | 43.0¢ | $72.64K | 164.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3355 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 15645 | 1 |
View Market Depth
| Last trade - 15.56pm 13/09/2024 (20 minute delay) ? |
| MVP (ASX) Chart |